Skip to main content
Top
Published in: Rheumatology International 8/2017

01-08-2017 | Genes and Disease

Association study of estrogen receptor alpha gene polymorphisms with bone mass assessed by quantitative ultrasound in young adults

Authors: María Correa-Rodriguez, Jacqueline Schmidt-RioValle, Blanca Rueda-Medina

Published in: Rheumatology International | Issue 8/2017

Login to get access

Abstract

Different genetic variants in estrogen receptor alpha (ESR1) have been shown to influence bone phenotypes including quantitative bone ultrasound in elderly. We aimed to investigate the role of ESR1 polymorphisms in bone mass assessed by calcaneal quantitative ultrasound (QUS) in a population of young adults. The study sample consisted of 466 healthy individuals of Caucasian ancestry (315 females and 152 males) aged 18 and 25 years (median age 20.39 ± 2.70). Six ESR1 polymorphisms (rs302033, rs2982552, rs2982575, rs2504063, rs2234693-PvuII and rs9340799-XbaI) were selected as genetic markers and genotyped. Bone mass in the right calcaneus was estimated with QUS. In the unadjusted analysis, rs2982575 polymorphism was significantly associated with quantitative ultrasound parameter in the whole sample (p = 0.014, β (95% CI) = −0.114 (−1.023, −0.115). However, after adjusting for multiple confounding factors, this association did not remain significant. For the rest of the selected polymorphisms in ESR1, no significant association was observed with calcaneal parameter. Linkage disequilibrium analysis identified a single LD block for the ESR1 gene including PvuII and XbaI SNPs (pair-wise r 2 = 0.66). Our results revealed a lack of significant association between ESR1 polymorphisms and calcaneal quantitative ultrasound in a cohort of young adults suggesting that ESR1 gene do not play a major role in the acquisition of bone mass during early adulthood.
Literature
2.
go back to reference Kanis JA (2007) Assessment of osteoporosis at the primary health-care level. Technical Report Kanis JA (2007) Assessment of osteoporosis at the primary health-care level. Technical Report
3.
go back to reference Ralston SH, de Crombrugghe B (2006) Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20:2492–2506CrossRefPubMed Ralston SH, de Crombrugghe B (2006) Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20:2492–2506CrossRefPubMed
4.
go back to reference Krieg MA, Barkmann R, Gonnelli S et al (2008) Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD official positions. J Clin Densitom 11:163–187CrossRefPubMed Krieg MA, Barkmann R, Gonnelli S et al (2008) Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD official positions. J Clin Densitom 11:163–187CrossRefPubMed
5.
go back to reference Arden NK, Baker J, Hogg C et al (1996) The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res 11:530–534CrossRefPubMed Arden NK, Baker J, Hogg C et al (1996) The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins. J Bone Miner Res 11:530–534CrossRefPubMed
6.
go back to reference Lee M, Czerwinski SA, Choh AC et al (2004) Heritability of calcaneal quantitative ultrasound measures in healthy adults from the Fels Longitudinal Study. Bone 35:1157–1163CrossRefPubMed Lee M, Czerwinski SA, Choh AC et al (2004) Heritability of calcaneal quantitative ultrasound measures in healthy adults from the Fels Longitudinal Study. Bone 35:1157–1163CrossRefPubMed
7.
go back to reference Bonjour J-P, Chevalley T, Ferrari S, Rizzoli R (2009) The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex 51:s5–s17CrossRefPubMed Bonjour J-P, Chevalley T, Ferrari S, Rizzoli R (2009) The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex 51:s5–s17CrossRefPubMed
8.
go back to reference Berger C, Goltzman D, Langsetmo L et al (2010) Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res 25:1948–1957CrossRefPubMedPubMedCentral Berger C, Goltzman D, Langsetmo L et al (2010) Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res 25:1948–1957CrossRefPubMedPubMedCentral
9.
go back to reference Guéguen R, Jouanny P, Guillemin F et al (1995) Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 10:2017–2022CrossRefPubMed Guéguen R, Jouanny P, Guillemin F et al (1995) Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 10:2017–2022CrossRefPubMed
11.
12.
go back to reference Binh TQ, Shinka T, Khan NC et al (2006) Association of estrogen receptor alpha gene polymorphisms and lifestyle factors with calcaneal quantitative ultrasound and osteoporosis in postmenopausal Vietnamese women. J Hum Genet 51:1022–1029CrossRefPubMed Binh TQ, Shinka T, Khan NC et al (2006) Association of estrogen receptor alpha gene polymorphisms and lifestyle factors with calcaneal quantitative ultrasound and osteoporosis in postmenopausal Vietnamese women. J Hum Genet 51:1022–1029CrossRefPubMed
13.
go back to reference Tang L, Cheng G-L, Xu Z-H et al (2013) Association between estrogen receptor α gene (ESR1) PvuII (C/T) and XbaI (A/G) polymorphisms and hip fracture risk: evidence from a meta-analysis. PLoS ONE 8:e82806CrossRefPubMedPubMedCentral Tang L, Cheng G-L, Xu Z-H et al (2013) Association between estrogen receptor α gene (ESR1) PvuII (C/T) and XbaI (A/G) polymorphisms and hip fracture risk: evidence from a meta-analysis. PLoS ONE 8:e82806CrossRefPubMedPubMedCentral
14.
go back to reference Ioannidis JPA, Ralston SH, Bennett ST et al (2004) Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292:2105–2114CrossRefPubMed Ioannidis JPA, Ralston SH, Bennett ST et al (2004) Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292:2105–2114CrossRefPubMed
15.
go back to reference Massart F, Marini F, Bianchi G et al (2009) Age-specific effects of estrogen receptors’ polymorphisms on the bone traits in healthy fertile women: the BONTURNO study. Reprod Biol Endocrinol 7:32CrossRefPubMedPubMedCentral Massart F, Marini F, Bianchi G et al (2009) Age-specific effects of estrogen receptors’ polymorphisms on the bone traits in healthy fertile women: the BONTURNO study. Reprod Biol Endocrinol 7:32CrossRefPubMedPubMedCentral
16.
go back to reference Albagha OME, Pettersson U, Stewart A et al (2005) Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone. J Med Genet 42:240–246CrossRefPubMedPubMedCentral Albagha OME, Pettersson U, Stewart A et al (2005) Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone. J Med Genet 42:240–246CrossRefPubMedPubMedCentral
17.
go back to reference Rojano-Mejía D, Coral-Vázquez RM, Coronel A et al (2014) Relation of the estrogen receptor and vitamin D receptor polymorphisms with bone mineral density in postmenopausal Mexican-mestizo women. Gene 537:10–14CrossRefPubMed Rojano-Mejía D, Coral-Vázquez RM, Coronel A et al (2014) Relation of the estrogen receptor and vitamin D receptor polymorphisms with bone mineral density in postmenopausal Mexican-mestizo women. Gene 537:10–14CrossRefPubMed
18.
go back to reference Wang K-J, Shi D-Q, Sun L-S et al (2012) Association of estrogen receptor alpha gene polymorphisms with bone mineral density: a meta-analysis. Chin Med J 125:2589–2597PubMed Wang K-J, Shi D-Q, Sun L-S et al (2012) Association of estrogen receptor alpha gene polymorphisms with bone mineral density: a meta-analysis. Chin Med J 125:2589–2597PubMed
19.
go back to reference Gennari L, Becherini L, Masi L et al (1998) Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab 83:939–944CrossRefPubMed Gennari L, Becherini L, Masi L et al (1998) Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab 83:939–944CrossRefPubMed
20.
go back to reference Valero C, Zarrabeitia MT, Hernández JL et al (2005) Bone mass in young adults: relationship with gender, weight and genetic factors. J Intern Med 258:554–562CrossRefPubMed Valero C, Zarrabeitia MT, Hernández JL et al (2005) Bone mass in young adults: relationship with gender, weight and genetic factors. J Intern Med 258:554–562CrossRefPubMed
21.
go back to reference Sowers M, Jannausch ML, Liang W, Willing M (2004) Estrogen receptor genotypes and their association with the 10-year changes in bone mineral density and osteocalcin concentrations. J Clin Endocrinol Metab 89:733–739CrossRefPubMed Sowers M, Jannausch ML, Liang W, Willing M (2004) Estrogen receptor genotypes and their association with the 10-year changes in bone mineral density and osteocalcin concentrations. J Clin Endocrinol Metab 89:733–739CrossRefPubMed
22.
go back to reference Koller DL, Zheng HF, Karasik D et al (2013) Meta-analysis of genome-wide studies identifies WNT16 and ESR1 SNPs associated with bone mineral density in premenopausal women. J Bone Miner Res 28:547–558CrossRefPubMedPubMedCentral Koller DL, Zheng HF, Karasik D et al (2013) Meta-analysis of genome-wide studies identifies WNT16 and ESR1 SNPs associated with bone mineral density in premenopausal women. J Bone Miner Res 28:547–558CrossRefPubMedPubMedCentral
23.
go back to reference Rivadeneira F, Styrkársdottir U, Estrada K et al (2009) Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 41:1199–1206CrossRefPubMedPubMedCentral Rivadeneira F, Styrkársdottir U, Estrada K et al (2009) Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 41:1199–1206CrossRefPubMedPubMedCentral
24.
go back to reference Moayyeri A, Hsu YH, Karasik D et al (2014) Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. Hum Mol Genet 23:3054–3068CrossRefPubMedPubMedCentral Moayyeri A, Hsu YH, Karasik D et al (2014) Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. Hum Mol Genet 23:3054–3068CrossRefPubMedPubMedCentral
25.
go back to reference Craig CL, Marshall AL, Sjostrom M et al (2003) International physical activity questionnaire: 12 country reliability and validity. Med Sci Sport Exerc 35:1381–1395CrossRef Craig CL, Marshall AL, Sjostrom M et al (2003) International physical activity questionnaire: 12 country reliability and validity. Med Sci Sport Exerc 35:1381–1395CrossRef
26.
27.
go back to reference Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefPubMed Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefPubMed
28.
go back to reference Scheffler C, Gniosdorz B, Staub K, Rühli F (2014) Skeletal robustness and bone strength as measured by anthropometry and ultrasonography as a function of physical activity in young adults. Am J Hum Biol 26:215–220CrossRefPubMed Scheffler C, Gniosdorz B, Staub K, Rühli F (2014) Skeletal robustness and bone strength as measured by anthropometry and ultrasonography as a function of physical activity in young adults. Am J Hum Biol 26:215–220CrossRefPubMed
29.
go back to reference Babaroutsi E, Magkos F, Manios Y, Sidossis LS (2005) Lifestyle factors affecting heel ultrasound in Greek females across different life stages. Osteoporos Int 16:552–561CrossRefPubMed Babaroutsi E, Magkos F, Manios Y, Sidossis LS (2005) Lifestyle factors affecting heel ultrasound in Greek females across different life stages. Osteoporos Int 16:552–561CrossRefPubMed
30.
go back to reference Andermann A, Blancquaert I (2010) Genetic screening: a primer for primary care. Can Fam physician Médecin Fam Can 56:333–339 Andermann A, Blancquaert I (2010) Genetic screening: a primer for primary care. Can Fam physician Médecin Fam Can 56:333–339
31.
go back to reference Qiu C, Chen H, Wen J et al (2013) Associations between age at menarche and menopause with cardiovascular disease, diabetes, and osteoporosis in Chinese women. J Clin Endocrinol Metab 98:1612–1621CrossRefPubMed Qiu C, Chen H, Wen J et al (2013) Associations between age at menarche and menopause with cardiovascular disease, diabetes, and osteoporosis in Chinese women. J Clin Endocrinol Metab 98:1612–1621CrossRefPubMed
Metadata
Title
Association study of estrogen receptor alpha gene polymorphisms with bone mass assessed by quantitative ultrasound in young adults
Authors
María Correa-Rodriguez
Jacqueline Schmidt-RioValle
Blanca Rueda-Medina
Publication date
01-08-2017
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 8/2017
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3748-8

Other articles of this Issue 8/2017

Rheumatology International 8/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.